TRIMTECH Therapeutics
TRIMTECH Therapeutics treats inflammatory and persistent CNS conditions by focusing on the elimination of harmful proteins.
$14M Seed ·
Led by Johnson & Johnson Innovation · Source: finsmes.com
Total raised: $45M across 2 sourced rounds
All 2 rounds ↓Signals
Website registeredJan 31, 2023 (3 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | $14M | finsmes.com | ||
| Seed | $31M | — | startupintros.com |
Timeline
- Website created
Founders and team
DC
Damian Crowther FounderLJ
Leo James FounderWM
William McEwan Founder
Investors
BBusiness Growth Fund
CCambridge Enterprise Ventures
CCambridge Innovation Capital
DDementia Discovery Fund
EEli Lilly
JJohnson & Johnson Innovationlead investor
MM Ventures
MMP Healthcare Venture Management
PPfizer Venture Investments
Companies like TRIMTECH Therapeutics
GGate BioSeed · Nov 2023DDiadem Biotherapeutics
SSFA TherapeuticsSeed · Jun 2022
EEccogene$25.2M Series B+ · Jun 2023AAltay Therapeutics
OOyster Therapeutics$60M Series A · Nov 2026
Other companies backed by Johnson & Johnson Innovation
TT-Therapeutics$133M Series B+ · Nov 2026
IIterative Health$77M Series B+ · Apr 2026
DDistalmotion$150M Series B+ · Nov 2025
CCitryll$92.5M Series B+ · Dec 2024
AAccent Therapeutics$75M Series B+ · Jan 2024
PPulmocide$52M Series B+ · Dec 2022
Johnson & Johnson Innovation portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/trimtech-therapeutics (get a free API key).